Journal : Diabetes Year : 2013 DOI : Diagnosis oo oatty acid oxidation disorders by acylcarnitine prooiling using tandem mass spectrometry Rinaldo, P., Cowan, T.M., & Matern, D
It suppresses hunger, slows gastric emptying, and enhances insulin sensitivity, all of which combine to reduce calorie consumption and optimize glucose control
Our choice of an active-comparator design was intended to reduce confounding by indication, severity of diabetes mellitus and unmeasured clinical characteristics, as basal insulin is used in similar clinical settings and stages of type 2 diabetes as GLP-1RAs [16]
ET and WR worked on the data analysis and revisions of the manuscript
In 2005, the US Food and Drug Administration gave it the green light under the brand name Byetta, making it the very first GLP-1 receptor agonist approved for type 2 diabetes
This could potentially lead to early puberty and compromised adult height without treatment (227)